These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 28362189)

  • 1. Canakinumab for the treatment of familial Mediterranean fever.
    Ozdogan H; Ugurlu S
    Expert Rev Clin Immunol; 2017 May; 13(5):393-404. PubMed ID: 28362189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial Mediterranean fever, review of the literature.
    Alghamdi M
    Clin Rheumatol; 2017 Aug; 36(8):1707-1713. PubMed ID: 28624931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial Mediterranean Fever.
    Ozdogan H; Ugurlu S
    Presse Med; 2019 Feb; 48(1 Pt 2):e61-e76. PubMed ID: 30686512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of familial Mediterranean fever who complained of periodic fever and abdominal pain diagnosed by MEFV gene analysis].
    Ogita C; Matsui K; Kisida D; Kakudou M; Yazaki M; Nakamura A; Azuma K; Tsuboi K; Abe T; Yokoyama Y; Furukawa T; Maruoka M; Tamura M; Yoshikawa T; Saito A; Nishioka A; Sekiguchi M; Azuma N; Kitano M; Tsunoda S; Hashimoto-Tamaoki T; Sano H
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(1):72-7. PubMed ID: 27181238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approach to the patients with inadequate response to colchicine in familial Mediterranean fever.
    Gül A
    Best Pract Res Clin Rheumatol; 2016 Apr; 30(2):296-303. PubMed ID: 27886801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature.
    Meinzer U; Quartier P; Alexandra JF; Hentgen V; Retornaz F; Koné-Paut I
    Semin Arthritis Rheum; 2011 Oct; 41(2):265-71. PubMed ID: 21277619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canakinumab as monotherapy for treatment of familial Mediterranean fever - first report in Central and Eastern Europe region.
    Jesenak M; Hrubiskova K; Kapustova L; Kostkova M; Banovcin P
    Bratisl Lek Listy; 2018; 119(4):198-200. PubMed ID: 29663815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Use of Interleukine-1 Inhibitors in Familial Mediterranean Fever Patients: A Narrative Review.
    Hentgen V; Vinit C; Fayand A; Georgin-Lavialle S
    Front Immunol; 2020; 11():971. PubMed ID: 32670263
    [No Abstract]   [Full Text] [Related]  

  • 9. Canakinumab as rescue therapy in familial Mediterranean fever refractory to conventional treatment.
    Alpa M; Roccatello D
    Drug Des Devel Ther; 2015; 9():1983-7. PubMed ID: 25945034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canakinumab in Children with Familial Mediterranean Fever: A Single-Center, Retrospective Analysis.
    Kisla Ekinci RM; Balci S; Dogruel D; Altintas DU; Yilmaz M
    Paediatr Drugs; 2019 Oct; 21(5):389-395. PubMed ID: 31463794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canakinumab treatment in children with familial Mediterranean fever: report from a single center.
    Yazılıtaş F; Aydoğ Ö; Özlü SG; Çakıcı EK; Güngör T; Eroğlu FK; Gür G; Bülbül M
    Rheumatol Int; 2018 May; 38(5):879-885. PubMed ID: 29450637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis.
    Varan Ö; Kucuk H; Babaoglu H; Guven SC; Ozturk MA; Haznedaroglu S; Goker B; Tufan A
    Mod Rheumatol; 2019 Mar; 29(2):363-366. PubMed ID: 29578360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canakinumab investigated for treating familial Mediterranean fever.
    Haviv R; Hashkes PJ
    Expert Opin Biol Ther; 2016 Nov; 16(11):1425-1434. PubMed ID: 27603969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes.
    De Benedetti F; Gattorno M; Anton J; Ben-Chetrit E; Frenkel J; Hoffman HM; Koné-Paut I; Lachmann HJ; Ozen S; Simon A; Zeft A; Calvo Penades I; Moutschen M; Quartier P; Kasapcopur O; Shcherbina A; Hofer M; Hashkes PJ; Van der Hilst J; Hara R; Bujan-Rivas S; Constantin T; Gul A; Livneh A; Brogan P; Cattalini M; Obici L; Lheritier K; Speziale A; Junge G
    N Engl J Med; 2018 May; 378(20):1908-1919. PubMed ID: 29768139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical role of anakinra in the armamentarium against familial Mediterranean fever.
    Parlar K; Ates MB; Egeli BH; Ugurlu S
    Expert Rev Clin Immunol; 2024 May; 20(5):441-453. PubMed ID: 38133629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of anti- IL-1 treatment in three patients with coexisting familial Mediterranean fever and multiple sclerosis.
    Ozdogan H; Ugurlu S; Uygunoglu U; Tutuncu M; Gul A; Akman G; Siva A
    Mult Scler Relat Disord; 2020 Oct; 45():102332. PubMed ID: 32645635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Familial Mediterranean fever as representative autoinflammatory disease].
    Yamazaki K; Yamazaki T; Masumoto J; Suzuki A; Yazaki M; Agematsu K
    Rinsho Byori; 2009 Apr; 57(4):371-81. PubMed ID: 19489440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulated Th17 cells in a patient with familial Mediterranean fever associated with amyloid A amyloidosis in the treatment of canakinumab.
    Goto T; Miyazaki Y; Nakayamada S; Shiraishi N; Yoshinaga T; Tanaka Y; Nakamura T
    Mod Rheumatol Case Rep; 2023 Jan; 7(1):237-242. PubMed ID: 35349715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial mediterranean fever: a fascinating model of inherited autoinflammatory disorder.
    Portincasa P; Scaccianoce G; Palasciano G
    Eur J Clin Invest; 2013 Dec; 43(12):1314-27. PubMed ID: 24117178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of anti-interleukin-1 treatment on quality of life in children with colchicine-resistant familial Mediterranean fever: A single-center experience.
    Kurt T; Aydın F; Nilüfer Tekgöz P; Sezer M; Uncu N; Çelikel Acar B
    Int J Rheum Dis; 2020 Jul; 23(7):977-981. PubMed ID: 32558310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.